CMS advised Werfen on the deal, while Hogan Lovells advised Omixon.Werfen acquired Omixon Biocomputing. Werfen is a Barcelona-based healthcare company. Omixon Biocomputing is a transplant diagnostics…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
